Allogenic Thymocyte-Depleted Thymus Tissue-Agdc has 1 known drug interaction based on U.S. FDA drug labeling data. Notable interactions include combinations with Corticosteroids. Patients taking Allogenic Thymocyte-Depleted Thymus Tissue-Agdc should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 1
- Moderate
- 1
Moderate (1)
- Allogenic Thymocyte-Depleted Thymus Tissue-Agdc + Corticosteroids— Prolonged use of high-dose corticosteroids should be avoided if possible when using RETHYMIC due to immunosuppressive ef…